Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
B Raman, DA Bluemke, TF Lüscher… - European heart …, 2022 - academic.oup.com
Emerging as a new epidemic, long COVID or post-acute sequelae of coronavirus disease
2019 (COVID-19), a condition characterized by the persistence of COVID-19 symptoms …
2019 (COVID-19), a condition characterized by the persistence of COVID-19 symptoms …
[HTML][HTML] Disulfiram inhibits neutrophil extracellular trap formation and protects rodents from acute lung injury and SARS-CoV-2 infection
Severe acute lung injury has few treatment options and a high mortality rate. Upon injury,
neutrophils infiltrate the lungs and form neutrophil extracellular traps (NETs), damaging the …
neutrophils infiltrate the lungs and form neutrophil extracellular traps (NETs), damaging the …
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective
S Halawa, SS Pullamsetti, CRM Bangham… - Nature Reviews …, 2022 - nature.com
The lungs are the primary target of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection, with severe hypoxia being the cause of death in the most critical cases …
CoV-2) infection, with severe hypoxia being the cause of death in the most critical cases …
Post-COVID syndrome: pulmonary complications
D Esendağli, A Yilmaz, MŞ AKÇAY… - Turkish journal of …, 2021 - journals.tubitak.gov.tr
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of
people worlwide and caused a pandemic that is still ongoing. The virus can cause a disease …
people worlwide and caused a pandemic that is still ongoing. The virus can cause a disease …
Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies
H Christou, RA Khalil - American Journal of Physiology …, 2022 - journals.physiology.org
Pulmonary hypertension (PH) is a serious disease characterized by various degrees of
pulmonary vasoconstriction and progressive fibroproliferative remodeling and inflammation …
pulmonary vasoconstriction and progressive fibroproliferative remodeling and inflammation …
Molecular pathways in pulmonary arterial hypertension
Pulmonary arterial hypertension is a multifactorial, chronic disease process that leads to
pulmonary arterial endothelial dysfunction and smooth muscular hypertrophy, resulting in …
pulmonary arterial endothelial dysfunction and smooth muscular hypertrophy, resulting in …
Cardiopulmonary exercise testing as a vital sign in patients recovering from COVID-19
Countries around the world continue to address the largescale health and wellbeing impacts
and the broader societal burden associated with the coronavirus disease 2019 (COVID …
and the broader societal burden associated with the coronavirus disease 2019 (COVID …
Severe pulmonary hypertension: an important sequel after severe post-acute COVID-19 pneumonia
G Cueto-Robledo, M Porres-Aguilar… - Current Problems in …, 2022 - Elsevier
Discussion According to data referring to previous epidemics, 70-80% of patients who
survived coronavirus infections such as SARS and MERS, presented respiratory …
survived coronavirus infections such as SARS and MERS, presented respiratory …
[HTML][HTML] Post pandemic research priorities: a consensus statement from the HL-PIVOT
We have been amid unhealthy living and related chronic disease pandemics for several
decades. These longstanding crises have troublingly synergized with the coronavirus …
decades. These longstanding crises have troublingly synergized with the coronavirus …
Recent advances and future prospects of treatment of pulmonary hypertension
Pulmonary hypertension is one of the difficult situations to treat. Complex pathophysiology,
association of the multiple comorbidities make clinical scenario challenging. Recently it is …
association of the multiple comorbidities make clinical scenario challenging. Recently it is …